Masayo Yoshimura

A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis

Yoshiaki Kinoshita, Makoto Hamasaki, Masayo Yoshimura et al. · Lung Cancer · 2018 · 58 citations

Medicine, Oncology, Pathology +10

Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia

Masayo Yoshimura, Yoshiaki Kinoshita, Makoto Hamasaki et al. · Lung Cancer · 2019 · 53 citations

Medicine, Oncology, Pathology +16

Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma

Makoto Hamasaki, Yoshiaki Kinoshita, Masayo Yoshimura et al. · Histopathology · 2019 · 40 citations

Medicine, Oncology, Pathology +16

Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma

Yoshiaki Kinoshita, Makoto Hamasaki, Masayo Yoshimura et al. · Modern Pathology · 2019 · 35 citations · Full text

Medicine, Genetics, Oncology +14

Plasma Pituitary Hormone Responses to the Synthetic Enkephalin Analog (FK 33–824) in Normal Subjects and Patients with Pituitary Diseases*

R Demura, Toshihiro Suda, Ichiji Wakabayashi et al. · The Journal of Clinical Endocrinology & Metabolism · 1981 · 27 citations

Medicine, Endocrinology, Pharmacotherapy +17